Novonesis (Novozymes) B (MEX:NSISN) Cyclically Adjusted FCF per Share: MXN22.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:NSISN Novonesis (Novozymes) B MEX:NSISN
95 GF Score
Price MXN911.11
GF Value MXN936.38
! 5 Warning Signs
View Full Analysis

What is Novonesis (Novozymes) B Cyclically Adjusted FCF per Share?

Novonesis (Novozymes) B MEX:NSISN 95 Cyclically Adjusted FCF per Share is MXN22.00 as of Jun. 2026. GuruFocus rates MEX:NSISN with a GF Score™ of 95/100 and a GF Value™ of MXN936.38. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Novonesis (Novozymes) B's adjusted free cash flow per share for the three months ended in Jun. 2026 was MXN10.028. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN22.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Novonesis (Novozymes) B's average Cyclically Adjusted FCF Growth Rate was 6.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 1.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Novonesis (Novozymes) B was 8.90% per year. The lowest was 1.40% per year. And the median was 6.25% per year.

As of today (2026-09-17), Novonesis (Novozymes) B's current stock price is MXN911.11. Novonesis (Novozymes) B's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was MXN22.00. Novonesis (Novozymes) B's Cyclically Adjusted Price-to-FCF of today is 41.41.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Novonesis (Novozymes) B was 60.63. The lowest was 29.16. And the median was 44.45.


Novonesis (Novozymes) B  (MEX:NSISN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Novonesis (Novozymes) B's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=911.11/22.00
=41.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Novonesis (Novozymes) B was 60.63. The lowest was 29.16. And the median was 44.45.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Novonesis (Novozymes) B Cyclically Adjusted FCF per Share Related Terms


Novonesis (Novozymes) B Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Novonesis (Novozymes) B's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B Cyclically Adjusted FCF per Share Chart

Novonesis (Novozymes) B Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.22 31.55 23.55 21.01 22.05

Novonesis (Novozymes) B Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.80 23.09 22.05 23.30 22.00

MEX:NSISN vs LIN, SHW, ECL: Cyclically Adjusted FCF per Share Comparison

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B Cyclically Adjusted Price-to-FCF vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Cyclically Adjusted Price-to-FCF falls into.


MEX:NSISN
95GF Score
Novonesis (Novozymes) B MEX:NSISN
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novonesis (Novozymes) B Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novonesis (Novozymes) B's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=10.028/122.9500*122.9500
=10.028

Current CPI (Jun. 2026) = 122.9500.

Novonesis (Novozymes) B Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 8.330 100.200 10.221
201612 4.156 100.300 5.095
201703 6.553 101.200 7.961
201706 5.318 101.200 6.461
201709 7.766 101.800 9.379
201712 2.891 101.300 3.509
201803 4.085 101.700 4.939
201806 5.111 102.300 6.143
201809 10.896 102.400 13.083
201812 3.202 102.100 3.856
201903 4.256 102.900 5.085
201906 8.051 102.900 9.620
201909 8.476 102.900 10.128
201912 1.480 102.900 1.768
202003 10.100 103.300 12.021
202006 15.119 103.200 18.012
202009 8.233 103.500 9.780
202012 8.147 103.400 9.687
202103 8.188 104.300 9.652
202106 13.110 105.000 15.351
202109 10.257 105.800 11.920
202112 1.059 106.600 1.221
202203 4.061 109.900 4.543
202206 5.964 113.600 6.455
202209 4.464 116.400 4.715
202212 -3.179 115.900 -3.372
202303 -1.063 117.300 -1.114
202306 5.214 116.400 5.507
202309 9.951 117.400 10.421
202312 4.633 116.700 4.881
202403 5.215 118.400 5.415
202406 9.845 118.500 10.215
202409 8.578 118.900 8.870
202412 4.609 118.900 4.766
202503 2.419 120.200 2.474
202506 10.953 120.700 11.157
202509 16.588 121.600 16.772
202512 4.579 121.180 4.646
202603 3.302 121.670 3.337
202606 10.028 122.950 10.028

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN22.00 mean?
Novonesis (Novozymes) B (MEX:NSISN) has a Cyclically Adjusted FCF per Share of MXN22.00 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Novonesis (Novozymes) B and its competitors.
Is Novonesis (Novozymes) B's Cyclically Adjusted FCF per Share too high?
Novonesis (Novozymes) B's current Cyclically Adjusted FCF per Share is MXN22.00. Overall, Novonesis (Novozymes) B has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Novonesis (Novozymes) B's Cyclically Adjusted FCF per Share compare to LIN and SHW?
Novonesis (Novozymes) B's Cyclically Adjusted FCF per Share of MXN22.00 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Chemicals company?
A good Cyclically Adjusted FCF per Share depends on the Chemicals industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Novonesis (Novozymes) B and its competitors. Novonesis (Novozymes) B's current Cyclically Adjusted FCF per Share is MXN22.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novonesis (Novozymes) B stock overvalued right now?
Novonesis (Novozymes) B (MEX:NSISN) has a current Cyclically Adjusted FCF per Share of MXN22.00. The stock's GF Value™ is MXN936.38, compared to a current price of MXN911.11 — trading 2.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN22.00. Novonesis (Novozymes) B's overall GF Score™ is 95/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Novonesis (Novozymes) B (MEX:NSISN), the current Cyclically Adjusted FCF per Share is MXN22.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novonesis (Novozymes) B (MEX:NSISN) Overvalued in 2026?

Based on GuruFocus' analysis, Novonesis (Novozymes) B stock appears to be undervalued. The current stock price of MXN911.11 is trading 2.7% below its estimated GF Value™ of MXN936.38.

Key valuation signals for MEX:NSISN:

  • Cyclically Adjusted FCF per Share: MXN22.00
  • GF Value™: MXN936.38 vs. price of MXN911.11 (2.7% below fair value)
  • GF Score™: 95/100 with 5 warning signs

No single metric tells the full story. See the MEX:NSISN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novonesis (Novozymes) B Business Description

Address Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
95GF Score

Get the complete analysis for MEX:NSISN

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN911.11
Price
MXN936.38
GF Value